Comments
Loading...
Solid Biosciences (SLDB) Forecast
NewsEarningsSolid Biosciences (SLDB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSolid Biosciences (NASDAQ:SLDB) Stock Quotes, Forecast and News Summary
Solid Biosciences Stock (NASDAQ: SLDB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Solid Biosciences (SLDB) stock?
You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.
Who are Solid Biosciences (SLDB) competitors?
Other companies in Solid Biosciences’s space includes: Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Innate Pharma (NASDAQ:IPHA), Inozyme Pharma (NASDAQ:INZY) and Monopar Therapeutics (NASDAQ:MNPR).
What is the forecast, or price target, for Solid Biosciences (SLDB) stock?
Solid Biosciences has a consensus price target of $15.50.
What is the current price for Solid Biosciences (SLDB)?
The stock price for Solid Biosciences (NASDAQ: SLDB) is $4.435 last updated December 18, 2024 at 1:42 PM EST.
Does Solid Biosciences (SLDB) pay a dividend?
There are no upcoming dividends for Solid Biosciences.
When is Solid Biosciences (NASDAQ:SLDB) reporting earnings?
Solid Biosciences’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
Is Solid Biosciences (SLDB) going to split?
There is no upcoming split for Solid Biosciences.
What sector and industry does Solid Biosciences (SLDB) operate in?
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.